Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -21.02 | N/A |
PEG Ratio (TTM) | 0.01 | N/A |
P/S Ratio (TTM) | 3.53 | N/A |
P/B Ratio (TTM) | 4.37 | N/A |
P/FCF Ratio (TTM) | -31.16 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.18% | N/A |
ROE (TTM) | -20.80% | N/A |
Net Profit Margin (TTM) | -18.45% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -402.10% | N/A | N/A |
Revenue | 2,254.04% | N/A | N/A |
Net Income | -392.74% | N/A | N/A |
Cash Flow | 1,353.82% | N/A | N/A |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.34 | N/A |
Quick Ratio (TTM) | 0.77 | N/A |
D/E Ratio (TTM) | 0.76 | N/A |
Interest Coverage (TTM) | -10.21 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 1.70 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |